| Primary |
| Schizophrenia |
40.0% |
| Depressive Symptom |
20.0% |
| Insomnia |
20.0% |
| Parkinsonism |
20.0% |
|
|
| Secondary |
| Affect Lability |
14.7% |
| Depressive Symptom |
14.7% |
| Personality Disorder |
14.7% |
| Schizophrenia |
14.6% |
| Insomnia |
12.9% |
| Drug Use For Unknown Indication |
7.9% |
| Parkinsonism |
3.1% |
| Alcoholic Psychosis |
2.8% |
| Product Used For Unknown Indication |
2.7% |
| Depression |
1.7% |
| Diabetes Mellitus |
1.7% |
| Constipation |
1.5% |
| Drug Exposure During Pregnancy |
1.1% |
| Somatoform Disorder |
1.1% |
| Schizophrenia, Paranoid Type |
1.0% |
| Anxiety Disorder |
0.8% |
| Hallucination, Auditory |
0.8% |
| Insomnia Related To Another Mental Condition |
0.8% |
| Anxiety |
0.7% |
| Bipolar I Disorder |
0.6% |
|
| Pregnancy |
26.9% |
| Neurogenic Bladder |
10.3% |
| Pulmonary Embolism |
10.3% |
| Pollakiuria |
7.7% |
| Pneumonia Aspiration |
6.4% |
| Sudden Death |
3.8% |
| Tremor |
3.8% |
| Weight Increased |
3.8% |
| Altered State Of Consciousness |
2.6% |
| Cardiac Failure Acute |
2.6% |
| Death |
2.6% |
| Electrocardiogram Qt Prolonged |
2.6% |
| Neuroleptic Malignant Syndrome |
2.6% |
| Parkinsonism |
2.6% |
| Psychomotor Skills Impaired |
2.6% |
| Rash |
2.6% |
| Tremor Neonatal |
2.6% |
| Drug Ineffective |
1.3% |
| Electrolyte Imbalance |
1.3% |
| Hypothyroidism |
1.3% |
|
| Concomitant |
| Schizophrenia |
24.6% |
| Depression |
19.5% |
| Insomnia |
11.8% |
| Bipolar I Disorder |
7.3% |
| Bipolar Disorder |
6.3% |
| Drug Use For Unknown Indication |
3.9% |
| Hypertension |
3.1% |
| Dermatitis |
2.8% |
| Product Used For Unknown Indication |
2.6% |
| Schizophrenia, Paranoid Type |
2.5% |
| Anxiety Disorder |
1.9% |
| Obsessive-compulsive Disorder |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Anxiety |
1.5% |
| Hallucination, Auditory |
1.5% |
| Mania |
1.5% |
| Iron Deficiency Anaemia |
1.4% |
| Psychomotor Seizures |
1.4% |
| Somatoform Disorder |
1.4% |
| Bipolar Ii Disorder |
1.2% |
|
| Vomiting |
9.0% |
| Weight Decreased |
9.0% |
| Somnolence |
6.4% |
| Hypoacusis |
5.1% |
| Loss Of Consciousness |
5.1% |
| Neuroleptic Malignant Syndrome |
5.1% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
5.1% |
| Psychomotor Skills Impaired |
5.1% |
| Sudden Death |
5.1% |
| Thirst |
5.1% |
| Tinea Cruris |
5.1% |
| Altered State Of Consciousness |
3.8% |
| Dermatitis |
3.8% |
| Myocardial Infarction |
3.8% |
| Protein Urine Present |
3.8% |
| Pyrexia |
3.8% |
| Rash |
3.8% |
| Salivary Hypersecretion |
3.8% |
| Sedation |
3.8% |
| Sepsis |
3.8% |
|
| Interacting |
| Mentally Late Developer |
44.4% |
| Asthma |
22.2% |
| Onychomycosis |
22.2% |
| Drug Use For Unknown Indication |
11.1% |
|
| Rhabdomyolysis |
60.0% |
| Neuroleptic Malignant Syndrome |
20.0% |
| Urticaria |
20.0% |
|
